No Data
No Data
Option Care Health Upgraded at UBS on Valuation After Q1 Beat
Johnson & Johnson Receives FDA Approval For IMAAVYTM, A New FcRn Blocker Offering Long-Lasting Disease Control In The Broadest Population Of People Living With Generalized Myasthenia Gravis
Barclays Maintains Equal-Weight on WEC Energy Group, Raises Price Target to $101
WEC Energy Group Analyst Ratings
Nvidia, Johnson & Johnson, Hyundai, Toyota, SoftBank CEOs To Join Trump At White House As He Touts Investment Surge In First 100 Days: Report
Fomento Económico Mexicano, S.A.B. De C.V. (FMX) Q1 2025 Earnings Call Transcript Summary